ALEXANDRIA, Va., Sept. 17 -- United States Patent no. 12,415,808, issued on Sept. 16, was assigned to Gilead Sciences Inc. (Foster City, Calif.).

"Pyrrolo[1,2-bpyridazine derivatives" was invented by Stephen Ammann (Redwood City, Calif.), Elizabeth M. Bacon (Burlingame, Calif.), Gediminas Brizgys (San Carlos, Calif.), Elbert Chin (San Mateo, Calif.), Chienhung Chou (Dublin, Calif.), Jeromy J. Cottell (Redwood City, Calif.), Marilyn Ndukwe (Lebanon, N.H.), James G. Taylor (Burlingame, Calif.), Nathan E. Wright (San Diego), Zheng-Yu Yang (Palo Alto, Calif.) and Sheila M. Zipfel (Schaumburg, Ill.).

According to the abstract* released by the U.S. Patent & Trademark Office: "A compound of Formula (I):pharmaceutically acceptable salts thereof, ...